Aptose Net Working Capital from 2010 to 2026
| APS Stock | CAD 2.26 0.01 0.44% |
Net Working Capital | First Reported 2020-03-31 | Previous Quarter -5.7 M | Current Value -3.3 M | Quarterly Volatility 45.3 M |
Check Aptose Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aptose Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 27.4 K, Interest Expense of 159.5 K or Selling General Administrative of 6.8 M, as well as many indicators such as Price To Sales Ratio of 2.8 K, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Aptose financial statements analysis is a perfect complement when working with Aptose Biosciences Valuation or Volatility modules.
Aptose | Net Working Capital |
Evaluating Aptose Biosciences's Net Working Capital across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aptose Biosciences's fundamental strength.
Latest Aptose Biosciences' Net Working Capital Growth Pattern
Below is the plot of the Net Working Capital of Aptose Biosciences over the last few years. It is Aptose Biosciences' Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptose Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Net Working Capital | 10 Years Trend |
|
Net Working Capital |
| Timeline |
Aptose Net Working Capital Regression Statistics
| Arithmetic Mean | 25,121,271 | |
| Coefficient Of Variation | 140.11 | |
| Mean Deviation | 26,094,578 | |
| Median | 10,060,000 | |
| Standard Deviation | 35,196,988 | |
| Sample Variance | 1238.8T | |
| Range | 121.6M | |
| R-Value | 0.15 | |
| Mean Square Error | 1292.9T | |
| R-Squared | 0.02 | |
| Significance | 0.57 | |
| Slope | 1,023,059 | |
| Total Sum of Squares | 19821.2T |
Aptose Net Working Capital History
About Aptose Biosciences Financial Statements
Aptose Biosciences investors utilize fundamental indicators, such as Net Working Capital, to predict how Aptose Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 4.6 M | 4.3 M |
Other Information on Investing in Aptose Stock
Aptose Biosciences financial ratios help investors to determine whether Aptose Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aptose with respect to the benefits of owning Aptose Biosciences security.